跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 87,231 条关于
“killer cell lectin-like receptor G1”
全部
87,231
临床试验
59,340
药物
6,338
机构
351
资讯
21,202
去年
Abcuro Secures $200M Series C to Advance Phase II/III Trial for Rare Muscle Disease Treatment
去年
Abcuro Secures $200M Series C Funding to Advance Novel IBM Treatment Ulviprubart
7个月前
Abcuro's Ulviprubart Misses Primary Endpoints in Inclusion Body Myositis Trial, Shows Promise in Mild-to-Moderate Patients
11个月前
Senescent Immune Cells Drive Immunotherapy Resistance in Cancer Through SASP-Mediated Tumor Microenvironment Remodeling
12年前
Advancements in Natural Killer Cell Cancer Immunotherapy
去年
Dana-Farber Launches First Clinical Trial of Memory-Like Natural Killer Cells in Ovarian Cancer
2年前
Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients
去年
Indapta's IDP-023 Shows Promise in Multiple Myeloma and Enhanced NK Cell Activity
去年
Sintilimab/Chidamide Combination Shows Promising Results in Early-Stage Natural Killer T-Cell Lymphoma
2年前
Pharmacosmos Completes Strategic Acquisition of G1 Therapeutics in Multi-Million Dollar Deal
第 1 页，共 2121 页
上一页
下一页
